pick nuclear transfer ips says ips cells not completely reprogrammed warped reprogramming process stable cloned es cells prove better suited therapy creating different es cell line patient probably not necessary says robert lanza chief scientific officer advanced cell technology marlborough massachusetts coauthor paper instead imagines scientists create banks cell lines serve patients needing replacement tissues possibility years away researchers plan compare ips cells es cells derived person work best drug screening making replacement tissues studies way work hampered united states federal funds not study cloned es cells notes mitalipov egli hopeful recent work bring experts studying cloned es cells soften